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Abstract  
 
Background and Objectives 
Worldwide, osteoarthritis (OA) is the major cause of musculoskeletal pain and mobility 
disability in elderly people. The objective of this randomised, double-blind, placebo-
controlled clinical trial was to evaluate the effectiveness of laser acupuncture on 
osteoarthritis knee (OAK) pain. Traditional acupuncture philosophy, treatment 
principles and techniques were integrated with modern laser technology. The study 
tested the null hypothesis that laser acupuncture does not reduce pain and stiffness 
and improve physical function in OAK. 
Study Design and Methods  
Forty participants screened against Kellgren-Lawrence OA scale 2-3 and other 
inclusion/exclusion criteria were randomised equally into two groups – active and 
sham laser acupuncture – using computer-generated sequential numbers. Both the 
operator and participants were blinded to allocation. 
An 810 nm 100mW Class 3B infra-red laser fitted with two identical probes – one 
active and one deactivated by the manufacturer – was used in the study. This type of 
laser provided a credible placebo arrangement because its invisible beam produces 
neither heat nor sensation when applied to the skin, thus eliminating potential bias.  
At each treatment, the laser delivered 18J for two minutes to two sets of OAK-specific 
acupuncture points targeting Phlegm Retention and Blood Stasis and the underlying 
causes and symptoms according to the TCM paradigm. The 13 acupuncture points 
were aimed at reducing dampness and swelling, tonifying the Kidney, clearing 
blockages and stagnation of Qi and Blood, and soothing the Liver. In terms of Western 
science, laser is known to regenerate osteoblasts and cartilage, and produce analgesic 
effects through the release of serotonin and endorphins.  
Treatments were administered three times a week over four weeks (i.e. a total of 12 
treatments). Assessments occurred at four-week intervals with four time points over 
three months using a General Linear Model with repeated measures. Data were 
vi 
 
 
analysed on an intention-to-treat basis.  All data were carried forward, limiting bias for 
the six participants who dropped out. Participants experienced no adverse effects.   
WOMAC (the gold standard for assessing OAK), VAS, McGill Pain Questionnaire, 
Credibility/Expectancy Questionnaire, Working Alliance Inventory and Multi-
dimensional Health Locus of Control measured treatment outcomes, plus the 
psychometric and placebo effects of the practitioner-patient relationship and the 
power of others respectively. 
Results  
Study results rejected the null hypothesis, accepting the alternative hypothesis that 
the novel integration of laser with TCM methods safely reduces OAK pain and stiffness 
and improves physical function.  All primary outcome measures scored p < 0.05.  The 
vascular density of acupuncture points appears to amplify two energy-transporting 
systems – one based on TCM channel theory; the other cellular and peripheral nerve 
transduction signaling believed to occur in photo-biomodulation – thus magnifying and 
accelerating healing and metabolic processes.  The study identified, for the first time, 
the importance of selecting optimum laser parameters, precise TCM diagnosis for OAK 
disease differentiation with specific acupuncture point formulae targeting the 
underlying causes and symptoms of OAK.  Additionally, placebo assessment measured 
the importance of the patient-practitioner relationship, bonding, faith and task 
compliance in working towards mutual treatment goals.   
Conclusion: The study indicates that irradiating specific acupuncture points 
according to the TCM paradigm offers a safe and effective treatment for OAK. Further 
studies are needed to confirm these findings.  
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